A Comprehensive Assessment of Hip Damage in Ankylosing Spondylitis, Especially Early Features (2021)
https://www.frontiersin.org/articles/10.3389/fimmu.2021.668969/full?&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&field=&journalName=Frontiers_in_Immunology&id=668969

TCR repertoire and CDR3 motif analyses depict the role of αβ T cells in Ankylosing spondylitis. (2019)
https://pubmed.ncbi.nlm.nih.gov/31477563/

Application and preliminary validation of the hip inflammation MRI scoring system (HIMRISS) in spondyloarthritis (2019)
https://pubmed.ncbi.nlm.nih.gov/30548414/

TNFAIP3-DEPTOR complex regulates inflammasome secretion through autophagy in ankylosing spondylitis monocytes (2018)
https://pubmed.ncbi.nlm.nih.gov/29940800/

Functional defects in CD4 + CD25 high FoxP3 + regulatory cells in ankylosing spondylitis (2016)
https://pubmed.ncbi.nlm.nih.gov/27901054/

Levels of circulating Th17 cells and regulatory T cells in ankylosing spondylitis patients with an inadequate response to anti-TNF-α therapy (2013)
https://pubmed.ncbi.nlm.nih.gov/22926407/